Healthcare Services · Key players

Top Rare Disease Clinical Trial Services companies

The 5 key players our Rare Disease Clinical Trial Services report profiles.

Key players in Rare Disease Clinical Trial Services

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Rare Disease Clinical Trial Services market
#CompanyWebsiteOur reports
1 IQVIA — 363 reports
2 ICON Plc — 165 reports
3 Parexel — 165 reports
4 Medpace — 66 reports
5 Syneos Health — 99 reports

Rare Disease Clinical Trial Services reports by place

All 33 places for Rare Disease Clinical Trial Services

Get the full Rare Disease Clinical Trial Services report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.